Sunday December 04, 2022 from 09:35 to 10:05
Presenter
Director, Preventive and Genomic Cardiology
McGill University Health Center
McGill University
Objectives
At the conclusion of this session, participants will be able to:
•Review major new evidence as it related to lipid management in 2023
•Overview of the use of apoB, non-HDL-C and lipoprotein(a) in clinical care
•Briefly review new therapies in development for dyslipidemia
Lectures by George Thanassoulis
| When | Session | Talk Title | Room |
|---|---|---|---|
|
Sun-04 08:20 - 10:35 |
Plenary - 1 | The CCS dyslipidemia guidelines - What's new and what's important? | |
|
Sun-04 11:00 - 12:00 |
A-08 - Applying the 2021 CCS Dyslipidemia Guidelines in Clinical Practice - George Thanassoulis | Applying the 2021 CCS Dyslipidemia Guidelines in Clinical Practice |